Key result
Higher admission plasma osmolality linked to ~3.7-fold greater in-hospital mortality in STEMI patients.
Why the study?
Does higher plasma osmolality predict increased all-cause mortality in STEMI patients treated with primary PCI?
Observational (n=3,748)
Does higher plasma osmolality predict increased all-cause mortality in STEMI patients treated with primary PCI?
Answers are grounded in this paper and cite their sources.
Higher plasma osmolality at admission is a strong predictor of both in-hospital and long-term all-cause mortality in STEMI patients undergoing primary PCI.
BACKGROUND: The aim of this study was to investigate the association of plasma osmolality with all-cause mortality in ST-segment elevation myocardial infarction (STEMI) patients treated with a primary percutaneous coronary intervention. METHODS: This study included 3748 patients (mean age 58.3±11.8 years, men 81%) with STEMI treated with primary percutaneous coronary intervention. The following formula was used to measure the plasma osmolality at admission: osmolality=1.86×sodium (mmol/l)+glucose (mg/dl)/18+BUN (mg/dl)/2.8+9. RESULTS: The patients were followed up for a mean period of 22±10 months. Patients with higher plasma osmolality had 3.7 times higher in-hospital (95% confidence interval: 2.7-5.1) and 3.2 times higher long-term (95% confidence interval: 2.5-4.1) all-cause mortality rates than patients with lower plasma osmolality. CONCLUSION: Plasma osmolality was found to be a predictor of both in-hospital and long-term all-cause mortality. Hence, plasma osmolality can be used to detect high-risk patients in STEMI.
No takes yet. Share an insight, caveat, or question.
Tatlısu et al. (2016) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=3,748). Higher plasma osmolality vs. Lower plasma osmolality was evaluated on In-hospital and long-term all-cause mortality (RR 3.7 (in-hospital), RR 3.2 (long-term), 95% CI 2.7-5.1 (in-hospital), 2.5-4.1 (long-term)). Higher plasma osmolality at admission was associated with 3.7 times higher in-hospital and 3.2 times higher long-term all-cause mortality in STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: